VaxServe remains committed in helping you provide your patients with Fluzone vaccine each flu season. While you are continuing to wrap up this current season, we are making preparations for the 2013-2014 Fluzone Reservation Season. We will be presenting to you very soon an offer that includes discounted Fluzone pricing for the 2013-2014 season, favorable payment terms, and risk sharing for your program. Here are a few reasons why you have chosen Fluzone Vaccine as your influenza vaccine of choice and VaxServe as your product distributor.

Sanofi Pasteur and VaxServe remain the market leader through 2012-2013 influenza season:

• Sanofi Pasteur: Incomparable track record and experience
• 40 years of experience producing Fluzone vaccine
• Continually meeting customer commitments with quantity requested and delivery times
• Sanofi Pasteur: Unrivaled capacity 
• Two US influenza vaccine manufacturing facilities
• Capacity to manufacture up to 150 million total doses of trivalent inactivated vaccine
• Sanofi Pasteur: Unmatched portfolio
• Indication starting at 6 months of age
• Robust pipeline including quadrivalent and universal vaccines
• Continued investigation of new technologies, innovative products, and manufacturing efficiencies
• VaxServe: Specialty distributor that focuses on vaccines
• Relationship with Sanofi Pasteur, manufacturer of Fluzone vaccine 
• Representatives available to answer any questions about Fluzone vaccine

Thank you again for another successful influenza season and we look forward to working with you throughout the 2013-2014 season.

VaxServe